Introduction
============

The world is facing an aging phenomenon due to individuals living longer than ever before. In 2015, 901 million people were aged ≥60 years, with most of these individuals living in developed countries. This number is expected to more than double by 2050, reaching 2.1 billion (ie, 20% of the global population). Moreover, the number of people aged \>80 years is growing more rapidly than the general elderly population. Approximately 14% of the elderly population (125 million) were ≥80 years in 2015, and this number is expected to triple by 2050, reaching 434 million (approximately 20% of the senior population).[@b1-ppa-12-1003] This phenomenon puts clear pressure on health care systems and social service support structures. Older adults typically exhibit the co-occurrence of multiple conditions and chronic diseases, which makes their care, particularly their use of medications, a challenging task. Indeed, more than 90% of older adults are prescribed drugs, 50% of whom take five or more drugs and 10% of whom take 10 or more.[@b2-ppa-12-1003] Prevalence of polypharmacy (defined as at least five prescribed medications) in the elderly increases with age. It is reported that 36%--49% of patients \>75 years are prescribed polymedication, with differences related to the cohort considered and to nationality.[@b3-ppa-12-1003]--[@b6-ppa-12-1003] Nonadherence to medication and to medical plans, in general, are well-recognized public health problems. It is a challenge for researchers and health care providers as numerous efforts to improve patient adherence and persistence appear to be ineffective.[@b7-ppa-12-1003] This is particularly important in older adults due to the high number of coexisting chronic diseases and geriatric syndromes.

We must, therefore, deal with new challenges in a more holistic health care supervision and support of the elderly, both in health care systems and in home-settings, to enable the management of highly complex issues that require the integration of competencies of different social and health care professionals. Older people's adherence to medical plans constitutes an essential part of this trip toward adding quality to life rather than adding years to life.

When considering the definition of adherence, it must be considered that many different languages are spoken, leading to misunderstandings and incomprehension. Many different terms have been interchangeably used to describe adherence, which leaves a significant level of confusion. Adherence to medication is the term that is most commonly used, thanks to the World Health Organization definition of adherence[@b8-ppa-12-1003] and the ABC taxonomy.[@b9-ppa-12-1003] Nevertheless, even though it constitutes a clinical and scientific cornerstone, it may not adequately describe the need for a holistic adherence approach when dealing with the older population. Do we therefore need to rethink the culture of adherence in the elderly? Perhaps we need to integrate some unusual aspects that mainly characterize the older generation and that have been unforeseen or underestimated to date.

Toward a dedicated perspective on adherence in the elderly
==========================================================

It is uncommon for an older person to follow their therapeutic regimen on their own; for example, a formal or informal caregiver usually plays an essential role in adherence,[@b10-ppa-12-1003] as well as occurring in pediatric care.[@b11-ppa-12-1003] At the same time, clinical experience suggests that caregivers may often become a patient themselves. Therefore, should we speak of a patient's adherence or a family's adherence? Moreover, whenever a paid caregiver is involved in the care process, we should also consider the environmental context (ie, caregiver's adherence). Interventions aimed at improving adherence in the elderly population should therefore not only be individually oriented but also be family and caregiver oriented.[@b12-ppa-12-1003],[@b13-ppa-12-1003] Hence, a new definition of the concept of adherence needs to consider its changing nature, accepting that adherence is a process and not a status. It should be well illustrated with expectations from the medication review, and together with patients and their caregivers, renegotiate the medication regimen.[@b14-ppa-12-1003],[@b15-ppa-12-1003]

Moreover, increased adherence not only positively impacts on patients' health but also allows cost savings in the health care system to be achieved and productivity improvements in the economy. To increase adherence in the elderly may reduce payout due to slower disease progression and lower recurrence of relapse episodes. On the other hand, it may increase payout due to increased medication use and short-term services too. However, the balance is positive for insurances.[@b16-ppa-12-1003]

With regards to multimorbidity, the same individual may express different levels of adherence to different medications due to prioritization and individual health-belief models.[@b14-ppa-12-1003] Nevertheless, clinical trials seldom include the elderly and rarely focus on polypharmacy. The conceptual change should therefore accept a move toward a systemic view and away from a disease-specific position. Moreover, adherence is not always the result of an international and active behavioral process influenced by beliefs, feelings and environmental factors. On the contrary, in this kind of population the non-intentional adherence is an issue. Indeed, the elderly often deal with physiological decline of their sensorial, functional and cognitive capacities, as well as with neurodegenerative diseases. Poverty of cognitive resources contributes to the difficulty in fully understanding and managing medical prescriptions. The difficulties grow exponentially as the coexisting pathologies and treatments increase.[@b17-ppa-12-1003] Indeed, it has been reported that adherence may be different in clinical populations throughout the aging and in the change in neuropsychological functioning.[@b18-ppa-12-1003]

Conclusions
===========

Therefore, what is the landscape of adherence in elderly nowadays? Do we need to implement a "one fits all model" or should our clinical approach fit each individual and thus meet the expectations of personalized medicine while maintaining a sound cost-effectiveness ratio? What about the questions regarding adherence in an elderly population? The need of a more individualized and socially supportive medical regimen has already been proposed.[@b19-ppa-12-1003],[@b20-ppa-12-1003] Besides that, we highlight the need of a more holistic approach to adherence to create a new and shared culture of adherence in the elderly. Clinicians, health and social care professionals, researchers and stakeholders need to talk the same language to advocate policy frameworks that put adherence, particularly in chronic patients, on national and regional agendas. Deserved attention should be given to education, the implementation of interventional tools and clinical needs.
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